JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.11% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
EXL Service
EXLS
$5.29B
| $211M | 0.02% |
4,761,466
-19,729
| -0.4% | -$853K |
|
|
PPLI
652
People Inc
PPLI
$2.97B
| $211M | 0.02% |
5,966,371
-896,935
| -13% | -$35.9M |
|
653
MPLX
MPLX
$60.1B
| $210M | 0.02% |
4,391,479
-1,318,574
| -23% | -$61.4M |
|
654
Nutrien
NTR
$32.1B
| $209M | 0.02% |
4,664,817
-8,164,015
| -64% | -$388M |
|
655
iShares Core Dividend Growth ETF
DGRO
$43.7B
| $207M | 0.02% |
3,378,330
+73,361
| +2% | +$4.63M |
|
656
Casella Waste Systems
CWST
$5.89B
| $206M | 0.02% |
1,951,050
-48,801
| -2% | -$5.15M |
|
657
Aflac
AFL
$60.7B
| $206M | 0.02% |
1,995,309
-1,152,327
| -37% | -$126M |
|
658
Verisk Analytics
VRSK
$23.6B
| $206M | 0.02% |
747,337
+53,502
| +8% | +$14.9M |
|
659
Colgate-Palmolive
CL
$73.6B
| $206M | 0.02% |
2,260,807
-561,956
| -20% | -$53.6M |
|
660
Steris
STE
$23.2B
| $202M | 0.02% |
983,698
-32,498
| -3% | -$7.13M |
|
661
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.22B
| $202M | 0.02% |
3,196,935
-8,160,142
| -72% | -$528M |
|
662
iShares Russell 3000 ETF
IWV
$20.4B
| $202M | 0.02% |
603,980
+152,260
| +34% | +$51.3M |
|
663
Universal Health Services
UHS
$9.94B
| $202M | 0.02% |
1,124,654
-72,883
| -6% | -$14.8M |
|
664
Paychex
PAYX
$43.1B
| $202M | 0.02% |
1,437,691
-2,402,159
| -63% | -$341M |
|
665
Nutanix
NTNX
$17.4B
| $201M | 0.02% |
3,282,134
+781,402
| +31% | +$51.1M |
|
666
Extra Space Storage
EXR
$31B
| $200M | 0.01% |
1,339,290
-693,714
| -34% | -$114M |
|
667
iShares Core S&P US Growth ETF
IUSG
$33.6B
| $200M | 0.01% |
1,434,056
+94,755
| +7% | +$13M |
|
668
PUT
Salesforce
CRM
$162B
| $199M | 0.01% |
596,300
-201,000
| -25% | -$64.1M |
|
669
Middleby
MIDD
$5.43B
| $197M | 0.01% |
1,455,373
-821,052
| -36% | -$113M |
|
670
Phillips 66
PSX
$89.5B
| $197M | 0.01% |
1,727,946
-1,666,724
| -49% | -$212M |
|
671
Ferrovial N.V. Ordinary Shares
FER
$47.3B
| $197M | 0.01% |
4,726,511
+109,146
| +2% | +$4.44M |
|
|
EXAS
672
DELISTED
Exact Sciences
EXAS
| $196M | 0.01% |
3,493,491
-1,762,792
| -34% | -$110M |
|
673
iShares ESG Optimized MSCI USA ETF
SUSA
$4.16B
| $196M | 0.01% |
1,611,260
+19,255
| +1% | +$2.36M |
|
674
monday.com
MNDY
$3.7B
| $196M | 0.01% |
830,582
+78,267
| +10% | +$21.7M |
|
675
Jazz Pharmaceuticals
JAZZ
$16.1B
| $196M | 0.01% |
1,587,541
+72,007
| +5% | +$8.49M |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.